Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

7 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors Associated with the Selection of First-line Bevacizumab plus Chemotherapy and Clinical Response in HER2-negative Metastatic Breast Cancer: ONCOSUR AVALOX Study.
Manso L, Palomo AG, Pérez Carrión R, Cassinello J, Gallegos Sancho I, Chacón López-Muñiz I, Olier C, Fernández-Aramburo A, Llorca C, González X, Llorente R, Torregrosa D, Álvarez I, Gálve E, Bueno C, Garau I, García MJ, González-Santiago S, Ballesteros AI, Blanco E, Galán A, González S, Perelló A, Cortés-Funes H, Grávalos C. Manso L, et al. Among authors: chacon lopez muniz i. Anticancer Res. 2015 Dec;35(12):6941-50. Anticancer Res. 2015. PMID: 26637920
Safety of eribulin as third-line chemotherapy in HER2-negative, advanced breast cancer pre-treated with taxanes and anthracycline: OnSITE study.
Manso L, Moreno Antón F, Izarzugaza Perón Y, Delgado Mingorance JI, Borrega García P, Echarri González MJ, Martínez-Jañez N, López-González A, Olier Garate C, Ballesteros García A, Chacón López-Muñíz I, Ciruelos Gil E, García-Sáenz JA, Paz-Ares L. Manso L, et al. Among authors: chacon lopez muniz i. Breast J. 2019 Mar;25(2):219-225. doi: 10.1111/tbj.13199. Epub 2019 Feb 8. Breast J. 2019. PMID: 30734437 Clinical Trial.
18F-FDG semi-quantitative parameters and biological prognostic factors in locally advanced breast cancer.
García Vicente AM, Soriano Castrejón A, Relea Calatayud F, Muñoz Madero V, Molina Garrido MJ, León Martín AA, Cordero García JM, Pilkington Woll JP, Chacón López-Muñiz I, Palomar Muñoz A. García Vicente AM, et al. Among authors: chacon lopez muniz i. Rev Esp Med Nucl Imagen Mol. 2012 Nov-Dec;31(6):308-14. doi: 10.1016/j.remn.2011.12.001. Epub 2012 Mar 19. Rev Esp Med Nucl Imagen Mol. 2012. PMID: 23084013 Clinical Trial.
Semi-quantitative lymph node assessment of (18)F-FDG PET/CT in locally advanced breast cancer: correlation with biological prognostic factors.
García Vicente AM, Soriano Castrejón A, Cruz Mora MA, González Ageitos A, Muñoz Sánchez Mdel M, León Martín A, Espinosa Aunión R, Relea Calatayud F, Muñoz Madero V, Chacón López-Muñiz I, Cordero García JM, Jiménez Londoño GA. García Vicente AM, et al. Among authors: chacon lopez muniz i. Eur J Nucl Med Mol Imaging. 2013 Jan;40(1):72-9. doi: 10.1007/s00259-012-2244-3. Epub 2012 Sep 28. Eur J Nucl Med Mol Imaging. 2013. PMID: 23053321 Clinical Trial.
Mediastinal extravasation of doxorubicin.
Quintanar Verdúguez T, Blanco Jarava A, Martínez-Barbeito MB, Pangua Méndez C, López Gómez L, Andrade Santiago J, Chacón López-Muñiz I. Quintanar Verdúguez T, et al. Among authors: chacon lopez muniz i. Clin Transl Oncol. 2008 Feb;10(2):128-30. doi: 10.1007/s12094-008-0167-z. Clin Transl Oncol. 2008. PMID: 18258513
Molecular subtypes of breast cancer: metabolic correlation with ¹⁸F-FDG PET/CT.
García Vicente AM, Soriano Castrejón Á, León Martín A, Chacón López-Muñiz I, Muñoz Madero V, Muñoz Sánchez Mdel M, Palomar Muñoz A, Espinosa Aunión R, González Ageitos A. García Vicente AM, et al. Among authors: chacon lopez muniz i. Eur J Nucl Med Mol Imaging. 2013 Sep;40(9):1304-11. doi: 10.1007/s00259-013-2418-7. Epub 2013 Apr 30. Eur J Nucl Med Mol Imaging. 2013. PMID: 23632960
Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer.
von Minckwitz G, Procter M, de Azambuja E, Zardavas D, Benyunes M, Viale G, Suter T, Arahmani A, Rouchet N, Clark E, Knott A, Lang I, Levy C, Yardley DA, Bines J, Gelber RD, Piccart M, Baselga J; APHINITY Steering Committee and Investigators. von Minckwitz G, et al. N Engl J Med. 2017 Jul 13;377(2):122-131. doi: 10.1056/NEJMoa1703643. Epub 2017 Jun 5. N Engl J Med. 2017. PMID: 28581356 Free PMC article. Clinical Trial.